Bristol-Myers Squibb Company (BMV:BMY)

Mexico flag Mexico · Delayed Price · Currency is MXN
980.00
-48.00 (-4.67%)
Last updated: Jan 16, 2026, 12:33 PM CST
-15.17%
Market Cap1.94T
Revenue (ttm)881.05B
Net Income (ttm)110.77B
Shares Outn/a
EPS (ttm)54.49
PE Ratio17.53
Forward PE9.13
Dividend46.81 (4.78%)
Ex-Dividend DateJan 2, 2026
Volume661
Average Volume6,997
Open980.00
Previous Close1,028.00
Day's Range980.00 - 980.00
52-Week Range789.00 - 1,261.00
Beta0.30
RSI48.45
Earnings DateFeb 5, 2026

About BMV:BMY

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Sector Healthcare
Founded 1887
Employees 34,100
Stock Exchange Mexican Stock Exchange
Ticker Symbol BMY
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements